drugset / Trial / NCT01075217

Isovue in Peripheral Digital Subtraction Angiography (DSA)

NCT01075217

Phase 4 Completed 174 enrolled Bracco Diagnostics, Inc
RandomizedParallel-groupTriple-blindDiagnostic

Summary

No significant differences is expected in observed motion artifacts, heat or pain reported during peripheral DSA performed for diagnostic and/or endovascular therapeutic purposes.

Timeline

Start
2010-04
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iodixanol Diagnostic / imaging agent Other
Subject Iopamidol Diagnostic / imaging agent Other